Screening for lung cancer has come of age at a time when traditional approaches to mass screening are being challenged.1 For some cancers, physicians are moving slowly from a paternalistic model in which screening is considered mandatory for any patient who belongs to a defined high-risk group, to a newer patient-centered model in which the decision to screen is individualized and informed by a detailed discussion of potential benefits and harms. Conversations about cancer screening increasingly occur in the context of personalized medicine, individualized risk assessment, and shared decision making.
Gould MK. Who Should Be Screened for Lung Cancer? And Who Gets to Decide?. JAMA. 2016;315(21):2279-2281. doi:10.1001/jama.2016.5986